AURKB and glioblastoma: In the current study, we explored the anticancer activity of AdoMet in both stabilized and primary human GBM cell lines and provided the first evidence that AdoMet was able to inhibit DNA repair and to induce mitotic catastrophe through downmodulating the expression and activity of Aurora B kinase.